According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...

The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

Medical Dialogues team speaks with the lead authors of the research, Dr. Disha Chakraborty and Dr. Abhishek De from the Department of Dermatology, Calcutta National Medical College and Hospital, West ...

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...